Form 4: Progress Software CLO Reports RSU Vesting & Stock Sale
Insider Transaction Report
Progress Software's Chief Legal Officer, Yufan Stephanie Wang, reported the vesting of restricted stock units and subsequent sale of common stock under a pre-arranged trading plan.
Summary
- Yufan Stephanie Wang, Chief Legal Officer of Progress Software Corporation (PRGS), reported transactions involving common stock and restricted stock units (RSUs).
- On October 1, 2025, a total of 3,769 restricted stock units vested and converted into common stock on a one-for-one basis.
- Concurrently, 1,673 shares of common stock were withheld by the company to cover tax withholding obligations arising from the RSU vesting, at an average price of $44.21 per share.
- On October 3, 2025, 1,428 shares of common stock were sold at a price of $46.26 per share.
- The sale was executed pursuant to a pre-existing Rule 10b5-1 trading plan adopted on January 23, 2025.
- Following these transactions, the reporting person beneficially owns 668 shares of common stock directly.
- A total of 10,190 restricted stock units from grants on January 19, 2023, January 18, 2024, and January 23, 2025, remain as derivative securities, subject to future vesting.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions involving the vesting of equity compensation and a pre-planned sale of shares. This is a neutral event, reflecting standard executive compensation practices and personal financial planning, with no indication of positive or negative company-specific news.
Positives
- The vesting of restricted stock units represents earned compensation for the Chief Legal Officer, reflecting the successful fulfillment of equity incentive program conditions.
- The sale of common stock was conducted under a pre-existing Rule 10b5-1 trading plan, indicating a planned and orderly disposition of shares rather than a reaction to immediate market conditions or non-public information.
Negatives
- The Chief Legal Officer reduced her direct beneficial ownership of common stock from 2,096 shares to 668 shares following the sale, representing a decrease in direct equity alignment with shareholders.
Risks
- The Rule 10b5-1 trading plan was adopted prior to 'recent volatility in the Company's stock price,' which, while mitigating insider trading concerns, highlights the inherent market risk associated with the company's stock.
Future Outlook
The filing indicates that additional restricted stock units granted on January 19, 2023, January 18, 2024, and January 23, 2025, are subject to future vesting in semiannual installments, contingent on the Reporting Person's continued employment.
Industry Context
This Form 4 filing details a routine insider transaction, common across publicly traded companies, where executives receive equity compensation (RSUs) that vest over time and may subsequently sell shares for liquidity or diversification, often under pre-arranged trading plans. Such transactions are standard practice and generally do not reflect specific industry trends unless they are part of a broader pattern of insider activity within the sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Implementation | The sale of common stock was conducted under a Rule 10b5-1 trading plan, adopted on January 23, 2025, which is a corporate governance mechanism designed to allow insiders to sell shares without concerns about insider trading by pre-scheduling transactions. | 2025-01-23 | Enhances transparency and reduces potential for insider trading allegations by establishing a pre-arranged trading schedule for insider stock sales. |
Related Party Transactions
- The company withheld 1,673 shares of common stock to satisfy the Reporting Person's tax withholding obligations upon RSU vesting, which is a standard related-party transaction for equity compensation.
Stakeholder Impact
- Shareholders: Minor impact as the transaction is a routine insider sale under a pre-planned arrangement, not indicative of a change in company fundamentals.
- Employees: The vesting of RSUs demonstrates the company's ongoing equity compensation program for executives.
Next Steps
- Continued vesting of remaining restricted stock units from grants on January 19, 2023, January 18, 2024, and January 23, 2025, subject to the Reporting Person's continued employment with the company.
Key Dates
| Date | Description |
|---|---|
| 2022-06-30 | Grant of 2,760 restricted stock units to the Reporting Person pursuant to the Company's 2008 Stock Option and Incentive Plan. |
| 2023-01-19 | Grant of 6,419 restricted stock units to the Reporting Person pursuant to the Company's 2008 Stock Option and Incentive Plan. |
| 2023-04-01 | First semiannual vesting date for restricted stock units granted on June 30, 2022. |
| 2023-10-01 | First semiannual vesting date for restricted stock units granted on January 19, 2023. |
| 2024-01-18 | Grant of 6,226 restricted stock units to the Reporting Person pursuant to the Company's 2008 Stock Option and Incentive Plan. |
| 2024-10-01 | First semiannual vesting date for restricted stock units granted on January 18, 2024. |
| 2025-01-23 | Grant of 7,207 restricted stock units to the Reporting Person pursuant to the Company's 2008 Stock Option and Incentive Plan, and adoption of Rule 10b5-1 trading plan by the Reporting Person. |
| 2025-10-01 | Vesting of 3,769 restricted stock units, conversion to common stock, and withholding of 1,673 shares for tax obligations. |
| 2025-10-03 | Sale of 1,428 shares of common stock by the Reporting Person. |
Recommendation
holdThis Form 4 filing details a routine, pre-planned insider transaction involving the vesting of restricted stock units and a subsequent sale of shares. Such transactions are common for executives managing their personal finances and equity compensation and do not typically signal a change in the company's fundamental outlook or performance. Therefore, it does not warrant a change in investment recommendation; a 'hold' stance is appropriate as there's no new information to alter the investment thesis.
Keywords
Progress Software, PRGS, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Sale, Executive Compensation, 10b5-1 Plan, Chief Legal Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.